Malaysian health supplement maker DXN explores sale at $1b valuation

Malaysian health supplement maker DXN explores sale at $1b valuation

Capsules containing a blend of ginkgo biloba, ginseng and saffron extracts, called Sailuotong or SLT, are displayed for a photograph at the China Academy of Chinese Medical Sciences' Xiyuan Hospital in Beijing, China, on Tuesday, Sept. 25, 2018. Photographer: Giulia Marchi/Bloomberg

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter